...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: BIO Investor Forum, Oct 22-23
6
Sep 16, 2019 04:17PM
4
Oct 18, 2019 10:40AM
3
Oct 18, 2019 02:05PM
3
Oct 24, 2019 11:14AM
2
Oct 24, 2019 04:18PM
1
Oct 24, 2019 04:42PM
1
Oct 24, 2019 06:04PM
2
Oct 24, 2019 07:51PM

Thanks Bear - I had looked on clinicaltrials.gov last night also for the Keytruda combo trial and could find nothing. Something new is starting anyway so good! OT

Share
New Message
Please login to post a reply